acid and 3-(carbobenzoxyamino)-4,7-dihydroxy-8-methylcoumarin were identified as two new inhibitors of Micrococcus luteus DNAgyrase. Both compounds possess weak antibacterial activity against whole M. luteus cells which indicates that they probably lack efficient transport functions to penetrate the cell envelope.
their antibacterial activity by inhibiting the function of the B-subunit of the bacterial enzyme DNA gyrase. Novobiocin consists of three distinct entities: The sugar noviose (ring C), a coumarin residue MAR. 1988 (ring B) and 3/-isopentenyl-4-hydroxybenzoic acid (ring A). The subentity consisting of the noviose plus the coumarin is referred to as novenamine and the subentity consisting of the coumarin and the benzoic acid residue as novobiocic acid (Fig. 1) . Based on the observation that novenamine inhibits DNAgyrase but novobiocic acid does not we concluded in a previous report that novenamine is the active moiety in novobiocin0. Uponexamination of additional non-sugar containing novobiocinrelated coumarin analogs we now found two such compounds which also inhibit DNAgyrase.
Materials and Methods

DNAReplication and Repair in Toluenized Escherichia coli Cells
The mutant strain E. coli H560 deficient in DNApolymerase I (obtained from Dr. H. HoffmannBerling) was used to prepare toluenized cells. The specific methods used to grow the cells and toluenize them as well as the assay mixtures used to assess replicative and repair DNAsynthesis were as described previously2}. DNAGyrase DNAgyrase isolated from Micrococcus luteus was obtained from Bethesda Research Labs., Gaithersburg, Maryland. The enzyme was assayed in reaction mixtures containing in a total volume of 25 fi\: Tris-HCl (pH 7.5) 35 mM, MgCl2 20 him, KC1 20 mM, EDTA-Na2 0.1 dim, ATP 1 mM, spermidine 2 mM,mercaptoethanol 10 mM, 10 % glycerol, 0.5^g of relaxed covalently closed pBR322 DNA and 1 u of gyrase. Incubation was at 37°C for 30 minutes. Relaxed circular covalently closed DNAwas prepared by digesting super-coiled pBR322 DNAwith a 2-fold excess of topoisomerase I followed by ligation with T4 DNAligase according to standard procedures. The religated product contained mostly dimers of pBR322.
Antibacterial Activity
To assess antibacterial activity against whole M. luteus cells 0.015 /m of drug was dispensed on paper discs and the discs were placed on agar plates seeded with the indicator organism. Following incubation overnight the diameters of the resulting zones'of inhibition were read in mm.
Results
Each of the compounds was initially tested in a system assessing replicative DNAsynthesis. The system is based on permeabilized E. coli cells derived from a mutant deficient in DNApolymerase I, the repair enzyme. In this milieu DNAsynthesis is dependent on the four deoxyribonucleotides, the chromosome-replicative enzymecomplex in the cell and ATPas an energy source. This enzyme complex includes DNAgyrase which is essential for replicative DNAsynthesis. The system should thus allow the tentative identification of DNAgyrase inhibitors although it will also respond to other inhibitors such as DNAbinding agents and inhibitors of polymerase III.
The same system can be run in the repair mode. In this case no ATPis required and DNaseis supplied to induce damage to the chromosomal template thus initiating repair DNAsynthesis. This system does not require DNAgyrase functions and specific gyrase inhibitors have little or no effect on this system. An inhibitor of DNAgyrase should inhibit the replicative but not the repair system or the latter to a muchlesser extent. Hence inhibitors found active in the DNAreplication system were further tested in the repair system. The third systemapplied was a direct test on the isolated gyrase in which case relaxed covalently closed pBR322 plasmid DNAserved as the substrate of the enzyme. This system identifies gyrase inhibitors as well as DNAbinding agents, the latter interacting with the DNAsubstrate. Based on these three systems specific DNAgyrase inhibitors can be identified in that they should inhibit replicative DNAsynthesis, have little or no effect on DNArepair synthesis but inhibit the gyrase assay. Several novobiocin-related coumarins were first tested for inhibition of the replication system. Twoof these compounds, chlorobiocic acid and 3-(carbobenzoxyamino)-4,7-dihydroxy-8-methylcoumarin, significantly inhibited this system (Table 1) .
For the sake of brevity the latter compound will be referred to as carbobenzoxycoumarin in this communication. Chlorobiocic acid inhibited to the extent of' 77 %, carbobenzoxycoumarin to the extent of 60%, respectively.
The coumarin residue as present in novobiocin (ring B) (3-amino-4,7-dihydroxy-
The structures of these compounds are shown in Fig. 1 . The two inhibitors of DNA replication mentioned above were further tested in the DNA repair system where only negligible inhibitions were found (Table 1) . The specific DNAgyrase test revealed that both chlorobiocic acid as well as carbobenzoxycoumarin definitely inhibit DNA gyrase and thereby represent novel inhibitors of DNAgyrase (Fig. 2) .
Chlorobiocic acid and carbobenzoxycoumarin both possess weak inhibitory activity against whole M. luteus cells in an agar diffusion test system. The unsubstituted coumarin struc- Lanes from left to right: DNA-#mdIII digest, marker; relaxed pBR322 DNA, no gyrase; relaxed pBR322 DNA plus gyrase; novobiocin; chlorobiocic acid; carbobenzoxycoumarin.
Drug concentration, 0.5 mM.
ture (ring B) showed no antibacterial activity. Since chlorobiocic acid as well as the carbobenzoxycoumarin appear nearly as potent as novobiocin as M. luteus gyrase inhibitors but possess very weak antibacterial activity against whole M. luteus cells, it follows that the former two compoundsprobably can not penetrate the bacterial cell envelope efficiently which means that they lack good transport functions across the cell membrane.
Discussion
In earlier studies with the novobiocin fragments novenamineand novobiocic acid, novenamine proved active and novobiocic acid inactive against DNAgyrase. Based on this observation we then concluded that novenamine was the active moiety in novobiocin0. The studies presented here require a modification of this claim. Chlorobiocic acid and carbobenzoxycoumarin both lack the sugar moiety present in novenamine and are still very potent inhibitors of DNAgyrase. The unsubstituted coumarin residue (ring B) per se possesses no inhibitory activity. On the other hand this coumarin moiety is the only entity present in all the compoundsfound active such as novenamine, chlorobiocic acid and carbobenzoxycoumarin. This suggests but does not definitely prove that the coumarin moiety might be the essential entity required to interact with gyrase. Assuming the correctness of this hypothesis and considering the fact that the unsubstituted coumarin (ring B) does not inhibit gryase would point to the importance of proper substituent groups to impart inhibitory activity to the coumarin moiety. Novobiocic acid differs structurally from chlorobiocic acid in that a chlorine atom replaces a methyl group in the former to give the latter. As novobiocic acid lacks gyrase inhibitory activity while chlorobiocic acid is quite active, this drastic difference in biological activity can be ascribed to the difference imparted by replacement of a methyl group with a chlorine atom.
The results presented do not exclude the possibility that despite the presence of the coumarin moiety (ring B) in all the active compoundsthe two new gyrase inhibitors described represent new inhibitors in their own right.
